Category: News

A collaboration of researchers from Lausanne University Hospital, and the Universities of Lausanne, Basel and Bern have published data from the Swiss Helsana claims dataset (2014-2018). The researchers described the medications most commonly utilised in the treatment of chronic medical conditions in Switzerland. More information can be found here. Photo by Campaign Creators on Unsplash

Researchers from Universite de Montreal (Canada) and Manchester University (UK) have published a systematic review of studies describing IL-1 blockade in pregnancy. The review combines pregnancy exposure and outcome data following maternal anakinra and canakinumab use. More information can be found here.

Researchers from the Department of Clinical Pharmacology at Copenhagen University Hospital have published a nationwide register-based cohort study investigating the safety of early pregnancy ciprofloxacin exposure. The study, which included more than 10,000 ciprofloxacin exposed pregnancies, did not identify any increased risks of major malformation, organ-specific major malformations or miscarriage. More information can be found here.

Researchers have published their findings from a study into the ability of two international birthweight standards (customised GROW and INTERGROWTH-21st) to identify perinatal morbidity and mortality indicators associated with small for gestational age. The findings indicated that customised GROW assessments resulted in the increased identification of small for gestational age term babies. More information can be found here. Photo by Cassidy […]

Interim results have been published using data collected in the Biogen Multiple Sclerosis Pregnancy Exposure Registry. This latest study provides safety data for oral delayed-release dimethyl fumarate. More information can be found here. Photo by Robina Weermeijer on Unsplash

Researchers from the University of Copenhagen and Copenhagen University Hospital have published a large population-based observational study investigating the safety of gestational duloxetine use. The study was conducted using data from registers in Sweden and Denmark, and provided reassuring results regarding major congenital malformation and stillbirth risks. More information can be found here.

Researchers from Aalborg University have published a national cohort study investigating the risk of adverse pregnancy outcomes following first trimester anticoagulant exposure. More information can be found here.

Researchers from the OTIS Collaborative Research Group have conducted a prospective study of birth outcomes among 279 women who have taken hydroxycholoroquine in pregnancy. More details can be found here. Photo by Christina Victoria Craft on Unsplash